Lonza is committed to supporting your immunotherapy research by providing primary cells, media and both large- and small-volume transfection solutions to help your transition from research into therapy. If you’re ready for the clinic, our cell therapy services might be the answer you need for development, manufacturing and testing of your cell-based therapeutics.

Cells and Media

Whether you need purified natural killer cells, a mixed population of PBMCs, or unprocessed bone marrow, Lonza has the optimal cell and media solution you’re looking for. If you don’t see it in our catalog, we can likely isolate cells for you through our Cells on Demand Service.


Lonza’s Large-Volume 4D-Nucleofector™ LV Unit can transfect up to 1x109 cells without the need for re-optimization from your smaller-scale format. With this new addition to the established 4D-Nucleofector™ System, small- and large-scale transfection applications are seamless!

Clinical Cell Therapy Services

We partner with clients...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?